Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(Amendment No.1)
MARK ONE
x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period ended June 30, 2011 or
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to ________
COMMISSION FILE NUMBER: 0-11772
SPO MEDICAL INC.
(Exact name of registrant specified in its charter)
|
Delaware
|
25-1411971
|
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification No.)
|
3 Gavish Street, POB 2454, Kfar Saba, Israel
(Address of principal executive offices, including zip code)
972-9-966-2520
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a Smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ (Do not check if a smaller reporting company) smaller reporting company x
Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x .
As of August 19, 2011, SPO Medical Inc. had outstanding 33,565,673 shares of common stock, par value $0.01 per share.
EXPLANATORY NOTE
The purpose of this amendment on Form 10-Q/A to the quarterly report on Form 10-Q for the period ended June 30, 2011 Of SPO Medical Inc., filed with the Securities and Exchange Commission on August 22, 2011 (the “Form 10-Q”), is solely to furnish Exhibit 101 to the Form 10-Q, as required by Rule 405 of Regulation S-T.
No other changes have been made to the Form 10-Q. This Form 10-Q/A speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in Form 10-Q.
Pursuant to Rule 406T of Regulation S-T, the interactive data file included as Exhibit 101 hereto is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under those sections.
ITEM 6. EXHIBITS.
|
31*
|
Rule 13a - 14(a) Certification of Principal Executive Officer (and Principal Financial and Accounting Officer)
|
|
32*
|
Section 1350 Certification of Principal Executive Officer (and Principal Financial and Accounting Officer)
|
|
101.INS
|
|
XBRL Instance Document
|
| |
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
| |
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
| |
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
| |
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
| |
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
* Previously filed or furnished with SPO Medical Inc.’s Form 10-Q filed on August 22, 2011.
Pursuant to the requirements of the Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
DATE: September 14, 2011
|
/s/ Michael Braunold
|
| |
Michael Braunold
|
| |
Chief Executive Officer (Principal Executive
Officer and Principal
Financial and Accounting Officer) and Director
|